PMEL17 / Melanoma gp100 Antibody | V3931-100UG

PMEL17 / Melanoma gp100 Antibody | V3931-100UG | Gentaur US, UK & Europe Disrtribition

Family: Primary antibody

Formulation: 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide

Format: Purified

Clone: PMEL/2038

Host Animal: Mouse

Clonality: Monoclonal (mouse origin)

Species Reactivity: Human

Application: ELISA, IHC-P, WB

Buffer: N/A

Limitation: This Melanoma gp100 antibody is available for research use only.

Purity: Protein G affinity chromatography

Description: Cytotoxic T lymphocytes (CTL's) recognize melanoma-associated antigens, which belong to three main groups. These groups include tumor-associated testis-specific antigens, melanocyte differentiation antigens and mutated or aberrantly expressed antigens, which are routinely used as markers to identify melanomas based on their binding to specific monoclonal antibodies. gp100, also designated ME20-M, ME20-S and PMEL 17, is classified as a melanocyte differentiation antigen and is expressed at low levels in normal cell lines and tissues, but is upregulated in melanocytes. gp100 is a highly glycosylated protein. It is also the product of proteolytic cleavage, which results in a secreted protein.

The gp100 molecule is a 100kDa glycosylated protein that is cleaved into a small (26kDa) carboxy-terminal fragment and a larger amino- terminal section (60-64 kDa), which is subsequently cleaved to generate 26kDa and 34-38kDa fragments.

Immunogen: A portion of amino acids 376-502 from the human protein was used as the immunogen for the Melanoma gp100 antibody.

Storage: Store the Melanoma gp100 antibody at 2-8oC (with azide) or aliquot and store at -20 °C or colder (without azide).